Neuromonitoring equipment is very expensive and is only
available to people who can afford it as a therapeutic option. This factor
prevents the market from expanding. Moreover, due to the high cost of gadgets,
some healthcare institutions in rural areas, such as small hospitals and
dispensaries, cannot afford this expensive equipment for patient treatment.
In order to provide advanced technical diagnosis to
patients, healthcare professionals have chosen to use the latest technology in
neuromonitoring devices, which has led to a significant growth in the market
for neuromonitoring devices. In addition, the preference of patients and
healthcare providers for wearable neuromongering equipment to avoid unnecessary
hospital visits is expected to drive the market in the forecast period.
Explore More Insights@ https://www.alliedmarketresearch.com/request-sample/16980
According to a new report published by Allied Market
Research, titled, "Global Neuromonitoring Devices Market by Product and
Region: Global Opportunity Analysis and Industry Forecast, 2022-2030," the
global neuromonitoring devices market size was valued at $5,593.1 million in
2021, and global neuromonitoring devices market forecast is projected to reach
$10,276 million by 2030, growing with an expected CAGR of 7.24% from 2022 to
2030.
Impact Of Covid-19 on the Global Neuromonitoring Devices
Market
The Covid-19 epidemic has had a negative impact on the
market for neuromotor monitoring equipment. The high incidence of coronavirus
infection has led to a decrease in the number of hospital visits and admissions
of patients, which has led to a decline in the demand for neuromonitoring
equipment.
Due to the high prevalence of viral infections and serious
complications associated with the infection, healthcare professionals were
forced to postpone several neurosurgeries, which negatively impacted the demand
for neuromonitoring equipment.
With a high incidence of neurological diseases such as brain
tumors, epilepsy and epilepsy in humans, the global market for neuromonitoring
devices is expected to grow rapidly. Hospitalization and emergency department
admissions have increased in recent years as the incidence of the disease has
increased, leading to increasing demand for neuromonitoring equipment.
Key Market Players:
The key players profiled in this report include GE
Healthcare, Koninklijke Philips N.V., Medtronic Plc, Nihon Kohden Corporation,
Natus Medical Incorporated., Nuvasive, Inc., Advanced Brain Monitoring, Inc.,
Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.
The global market for neuromonitoring devices is divided by
product and region. According to the product, the market is classified as
Intracranial Pressure Monitoring, Cerebral Oximeter, Near-Infrared
Spectroscopy, Spectral Imaging, Doppler Ultrasound, EEG, Fetal / Neonatal
Neuromonitoring Equipment, Micro-Ultrasound and others. The fastest growing
subdivision is expected in products near infrared spectroscopy.
0 Comments